Dubai Final-v20.indd - World Allergy Organization
Dubai Final-v20.indd - World Allergy Organization
Dubai Final-v20.indd - World Allergy Organization
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
POstErs<br />
WAO IntErnAtIOnAl ScIEntIfIc cOnfErEncE<br />
Asthma and Co-morbid Conditions: Expanding the Practice of <strong>Allergy</strong> for Optimal Patient Care<br />
1401<br />
THE aSSoCiaTion BETWEEn DEgrEE oF SEnSiTiZaTion To allErgEn anD SEVEriTY oF allErgiC rHiniTiS<br />
n. s. mohd Ashari, W. m. Wm, n. K. Y, s. sah and C. m. CH<br />
Immunology, Universiti Sains Malaysia, Kota Bharu, Malaysia.<br />
1402<br />
Co-aDminiSTraTion oF CHEnoPoDiUm alBUm allErgEnS anD CPg oligoDEoXYnUClEoTiDES EFFECTS on PEriPHEral<br />
BlooD mononUClEar CEllS oF PaTiEnTS WiTH allErgiC rHiniTiS TrEaTED WiTH inTranaSal CorTiCoSTEroiDS anD<br />
anTiHiSTaminES<br />
s. Farrokhi sr., mD 1 , t. mousavi 1 , s. Arshi 1 , A. salekmoghadam 1 , A. Varasteh, PhD 2 and n. rezaei, mD, PhD 3<br />
1 Department of Immunology, Iran University of Medical Sciences, Tehran, Iran. 2 6. Immunobiochemistry Lab, Immunology Research<br />
Center, Avicenna Research Institute, 6. Immunobiochemistry Lab, Immunology Research Center, Avicenna Research Institute,<br />
Mashhad, ID, Iran. 3 Growth and Development Research Center, Children’s Medical Center, Tehran, Iran.<br />
1403<br />
TrEaTmET oF CHroniC allErgiC rHiniTiS:inTranaSal VS. oral THEraPY?<br />
A. Eatemadi<br />
Immunology & Infectious disease, Ahvaz university of medical sciences, Ahvaz, Iran.<br />
1404<br />
EFFiCaCY oF FEXoFEnaDinE in DiFFErEnT DoSagES For TrEaTmnET oF SEaSonal allErgiC rHiniTiS<br />
A. Eatemadi<br />
Immunology & Infectious disease, Ahvaz university of medical sciences, Ahvaz, Iran.<br />
1405<br />
THE moDiFiED SnoT-20 QUESTionnairE: rEPEaTaBiliTY anD aPPliCaBiliTY To rHiniTiS<br />
A. s. sami, mBBs, Bsc, ODtC, mCPs, mA, msc<br />
Ent, Royal National Throat, Nose and Ear Hospital, London, United Kingdom.<br />
1406<br />
a CommUniTY BaSED SUrVEY on THE PrEValEnCE oF rHiniTiS<br />
A. s. sami, mBBs, Bsc, ODtC, mCPs, mA, msc<br />
Ent, Royal National Throat, Nose and Ear Hospital, London, United Kingdom.<br />
1407<br />
EFFiCaCY oF mUlTiFaCETED aVoiDanCE mEaSUrES in THE managEmEnT oF PaTiEnTS WiTH PErSiSTEnT allErgiC<br />
rHiniTiS anD HoUSE DUST miTE allErgY<br />
s. s. Chao, FrCs and D. Y. Wang<br />
Department of Otolaryngology Head and Neck Surgery, National Univeristy of Singapore, Singapore, Singapore.<br />
1408<br />
EliminaTion oF oCUlar iTCHing BY oloPaTaDinE HCl oPHTHalmiC SolUTion, 0.2%<br />
m. s. Blaiss, mD1 , D. Amin, ms2 and m. tort, PhD3 1 2 3 University of Tennessee Health Science Center`, Memphis, TN. Global Medical Affairs, Alcon Research, Fort Worth, TX. Alcon<br />
Research ,Ltd, Fort Worth, TX.<br />
1409<br />
momETaSonE FUroaTE naSal SPraY inCrEaSES THE nUmBEr oF DaYS WiTH minimal SYmPTomS in PaTiEnTS WiTH<br />
aCUTE rHinoSinUSiTiS<br />
m. Danzig 1 , E. O. meltzer, mD 2 , D. gates 1 and g. gopalan, mD 3<br />
1 Schering-Plough Research Institute (now Merck Research Laboratories), Kenilworth, NJ. 2 <strong>Allergy</strong> and Asthma Medical Group &<br />
Research Center, San Diego, CA. 3 Merck & Co., Kenilworth, NJ.<br />
1410<br />
THE rECalCiTranT PoSTnaSal-DriP SYnDromE: THE grEaT CHallEngE For THE allErgiST-immUnologiST<br />
s. nsouli, mD, AnD, sEniOr, CliniCAl, rEsEArCH, AssOCiAtE<br />
Asthma and <strong>Allergy</strong>, DANVILLE ASTHMA AND ALLERGY CLINIC, CALIFORNIA, USA, Danville, CA.<br />
www.worldallergy.org 63<br />
FinAl PrOgrAm<br />
POstErs
Change language